Now Trending: Breast Cancer Awareness Month, Vaccine Hesitancy
Drug Topics
OCTOBER 5, 2024
Check out this recap of articles published on our sister sites during the past week.
Sat.Oct 05, 2024
112 
Opinion: Philanthropists Laura and John Arnold warn: Beware hospital consolidation
STAT
OCTOBER 5, 2024
Rampant consolidation in health care has resulted in higher prices for patients. This consolidation — whether by private equity firms or other large health systems — has not resulted in higher quality care, and in some cases, it has made care quality worse. In September, Ellen MacInnis, a nurse at St. Elizabeth’s Medical Center in Boston, trekked to Washington, D.C., to testify before a Senate committee about the extreme cost-savings measures mandated by the hosp
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Small Doses: September 30 to October 4
Drug Topics
OCTOBER 5, 2024
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Opinion: First Opinion readers on Hatch-Waxman, new-patient visit times, mpox, and more
STAT
OCTOBER 5, 2024
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Development and Manufacturing Advances for Microbiome-Derived Therapeutics (BIO 2024)
BioPharm
OCTOBER 5, 2024
During Bio 2024, Aaron Cowley, PhD, chief technical officer and co-founder, Captozyme, discussed the advancement in development of microbiome-derived therapeutics.
Pelabresib and Ruxolitinib Show Benefit in Treating Patients With JAK Inhibitor-Naïve Myelofibrosis
Pharmacy Times
OCTOBER 5, 2024
Pelabresib, a BET inhibitor, demonstrated meaningful reductions in spleen inflammation and anemia.
Let's personalize your content